ArticleInternational journal of clinical and experimental medicine2015
Favorable outcome of extended treatment with adding pegylated Interferonα-2a to entecavir for HBeAg-positive chronic hepatitis B: a case report.
Ying Zhang et al.PubMed ↗Full text ↗
No numbers read from the abstract.